Everything below concerns BPC 157. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
18 March to 28 February 1971 The 196th Light Infantry Brigade and ARVN 5th Regiment, 2nd Division launched Operation Frederick Hill to pacify the coastal areas of Quảng Tín Province. The operation results in 7,514 PAVN/VC killed and 133 captured, U.S. losses are 572 killed.
Moreover, for pathogen sequencing the use of controls is of fundamental importance ensuring mNGS assay quality and stability over time; PhiX is used as sequencing control, then the other controls include the positive control, an additional internal control (e.g., spiked DNA or other known pathogen) and a negative control (usually water sample). Bioinformatic analysis: Whereas the sequencing itself has been made widely accessible and more user friendly, the data analysis and interpretation that follows still requires specialized bioinformatics expertise and appropriate computational resources. The raw data from a sequencing platform is usually cleaned, trimmed, and filtered to remove low-quality and duplicate reads. Removal of the host genome/transcriptome reads is performed to decrease background noise (e.g., host and environmental reads) and increase the frequency of pathogen reads. This step will also decrease downstream analysis time. Further background noise removal is achieved by mapping of sample reads to the reads from the negative control to ensure elimination of any contaminating reads, such as those associated with the reagents or sampling storage medium. The remaining reads are usually assembled de novo to produce long stretches of sequences called contigs. Taxonomic identification of the resulting contigs is performed by matching them to the genomes and sequences in nucleotide or protein databases; for this, various versions of BLAST are most commonly used.
Cyprodime is a selective MOR antagonist Naltrindole is a selective DOR antagonist Norbinaltorphimine is a selective KOR antagonist J-113,397 is a selective nociceptin receptor (NOP) antagonist Other selective antagonists are also known, but the four listed above were the first selective antagonists discovered for each respective opioid receptor, and are still the most widely used. In addition to selective antagonists, AT-076 is a non-selective, balanced antagonist of all four of the opioid receptors, and was the first such agent to be discovered.
Biopreservation is the use of natural or controlled microbiota or antimicrobials as a way of preserving food and extending its shelf life. Beneficial bacteria or the fermentation products produced by these bacteria are used in biopreservation to control spoilage and render pathogens inactive in food. It is a benign ecological approach which is gaining increasing attention. Lactic acid bacteria (LAB) have antagonistic properties that make them particularly useful as biopreservatives. When LABs compete for nutrients, their metabolites often include active antimicrobials such as lactic acid, acetic acid, hydrogen peroxide, and peptide bacteriocins. Some LABs produce the antimicrobial nisin, which is a particularly effective preservative. LAB bacteriocins are used in the present day as an integral part of hurdle technology. Using them in combination with other preservative techniques can effectively control spoilage bacteria and other pathogens, and can inhibit the activities of a wide spectrum of organisms, including inherently resistant Gram-negative bacteria.
Sources: en.wikipedia.org
The Morgan State University Band Program consists of six ensembles: the marching band, symphonic band, symphonic winds, pep band, jazz ensemble, and jazz combo. Titled the Magnificent Marching Machine, the marching band has performed at Morgan State football games, NFL games, Presidential Inaugurations, World Series games and in regional and local television appearances. On November 28, 2019, the Magnificent Marching Machine performed during Macy's Thanksgiving Day Parade in New York City. They also performed at the 80th Anniversary and Commemoration of D-Day in Normandy, France on June 12, 2024.
Tandem mass spectrometry (MS/MS) is used to measure fragmentation spectra and identify proteins at high speed and accuracy. Collision-induced dissociation is used in mainstream applications to generate a set of fragments from a specific peptide ion. The fragmentation process primarily gives rise to cleavage products that break along peptide bonds. Because of this simplicity in fragmentation, it is possible to use the observed fragment masses to match with a database of predicted masses for one of many given peptide sequences. Tandem MS of whole protein ions has been investigated recently using electron capture dissociation and has demonstrated extensive sequence information in principle but is not in common practice.
=== Rise of the galactic city === The term "galactic city", associated with Lewis Mumford, describes a dispersed form of metropolitan development. Twentieth-century urban growth in parts of the United States was supported by several infrastructure and technological changes, including highway transportation, air conditioning, expanded agricultural production and systems for transporting and storing food over long distances. Refrigeration contributed to this broader infrastructure by allowing urban populations to obtain perishable food from distant agricultural regions rather than depending primarily on nearby production. In analyses of settlement patterns, refrigeration has therefore been identified as one of several technologies that reduced constraints on population growth in locations distant from traditional agricultural and transport centres.
Sources: en.wikipedia.org
In June 1963, a new terminal built for the jet age was dedicated, and the airport was rechristened Memphis Metropolitan Airport. United Nations ambassador Adlai Stevenson II spoke at the inauguration ceremony and replaced the ribbon cutting with a rocket launch. The terminal was designed by the local firm Mann & Harrover and became Roy Harrover's most famous work. It was one of the first airport terminals to have a two-level design where passengers boarded aircraft via jet bridges on the upper level and collected their luggage on the lower level. Another unique aspect of the structure was its columns resembling martini glasses. It opened to passengers in July and was part of an expansion project that also included a control tower and a north–south runway. In 1969, the Memphis–Shelby County Airport Authority was formed, and the facility changed its name to Memphis International Airport after being designated a customs port of origin. Expansion continued in the 1970s. A west concourse was added in 1974 and an east one the following year. The airport constructed another north–south runway, a parking garage, and a road linking the terminal to Interstate 240. The central concourse was extended as well. In 1988, the latter concourse was named B, the west one A, and the east one C.
== Characteristics == Various types of kōji are used, including yellow, black, and white. The kōji is stored for two to three days at 30°C under high humidity to allow A. oryzae to grow. In this process, the starch from cereals such as wheat, buckwheat or barley as well as from sweet potato is split into glucose, creating a sweet taste. The amino acids glutamic acid and to a lesser extent also aspartic acid split off from the proteins during fermentation, resulting in a strong umami taste. Depending on the Aspergillus used, culture substrate and culture conditions (temperature, pH value, salt content, humidity), different products are created in terms of composition, flavour and odour. Kōji can be freeze-dried and crushed to produce spores. Dried kōji-spores can be stored and transported light-protected at room temperature.
===== MeSH D08.811.913.477 – nitrogenous group transferases (EC 2.6) ===== MeSH D08.811.913.477.700 – transaminases MeSH D08.811.913.477.700.100 – alanine transaminase MeSH D08.811.913.477.700.120 – 2-aminoadipate transaminase MeSH D08.811.913.477.700.200 – 4-aminobutyrate transaminase MeSH D08.811.913.477.700.225 – aspartate aminotransferases MeSH D08.811.913.477.700.225.249 – aspartate aminotransferase, cytoplasmic MeSH D08.811.913.477.700.225.500 – aspartate aminotransferase, mitochondrial MeSH D08.811.913.477.700.286 – beta-alanine-pyruvate transaminase MeSH D08.811.913.477.700.347 – d-alanine transaminase MeSH D08.811.913.477.700.470 – Glutamate synthase (ferredoxin) MeSH D08.811.913.477.700.500 – glutamine-fructose-6-phosphate transaminase (isomerizing) MeSH D08.811.913.477.700.525 – glycine transaminase MeSH D08.811.913.477.700.535 – leucine transaminase MeSH D08.811.913.477.700.550 – l-lysine 6-transaminase MeSH D08.811.913.477.700.700 – ornithine-oxo-acid transaminase MeSH D08.811.913.477.700.800 – succinyldiaminopimelate transaminase MeSH D08.811.913.477.700.850 – tryptophan transaminase MeSH D08.811.913.477.700.900 – tyrosine transaminase
In enzymology, a protein xylosyltransferase (EC 2.4.2.26) is an enzyme that catalyzes the chemical reaction in which a beta-D-xylosyl residue is transferred from UDP-D-xylose to the sidechain oxygen atom of a serine residue in a protein. This enzyme belongs to the family of glycosyltransferases, specifically the pentosyltransferases. The systematic name of this enzyme class is UDP-D-xylose:protein beta-D-xylosyltransferase. Other names in common use include UDP-D-xylose:core protein beta-D-xylosyltransferase, UDP-D-xylose:core protein xylosyltransferase, UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase, UDP-xylose-core protein beta-D-xylosyltransferase, uridine diphosphoxylose-core protein beta-xylosyltransferase, and uridine diphosphoxylose-protein xylosyltransferase. This enzyme participates in the biosynthesis of chondroitin sulfate and glycan structures.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.